Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
PALI
PALISADE BIO, INC.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$1.35
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$235.27M
RECENT INSIDER TRADES
2026-10-07
· Finley John David
(CEO CFO)
· OTHER
2026-10-07
· Jones Mitchell Lawrence
(See Remarks)
· OTHER
2026-10-05
· Williams Donald Allen
(Director)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
126
Shares held
186,190,401
Value
$385.47M
Percent of shares outstanding
106.84%
As of quarter end
2026-06-30
RECENT NEWS
Palisade Bio director buys $28,800 in PALI stock
Palisade Bio stock initiated at Outperform by Raymond James
Palisade Bio to present PALI-2108 data for ulcerative colitis and Crohn's disease
Palisade Bio at Stifel forum: pde4 bet advances into phase 2
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
PALISADE BIO, INC. (PALI) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit